drugset / Trial / NCT07082842
Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A multicenter, parallel, randomized, placebo (double-blind) and pirfenidone (open-label) controlled Phase III clinical trial to evaluate the efficacy and safety of HEC585 in patients with idiopathic pulmonary fibrosis (IPF)
Timeline
- Start
- 2025-10-27
- Primary completion
- 2031-01-15
- Completion
- 2032-02-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HEC585 | Small molecule | — | — |
| Comparator | Pirfenidone | Small molecule | — | — |